TLR3 and viral infectious disease: While we cannot exclude the possibility that PBMCs from the PAE group may respond to TLR3 agonist at earlier or later time points than the 24 h post-stimulation, the differential sensitivity of circulatory immune cells to TLR3 agonist, observed in our study, may confer susceptibility to viral infections in children with FASDs.